Press releases

July 27, 2011 - Polyphor and Axxam announce EU funded R&D collaboration for the treatment of Type-2 Diabetes.

May 6, 2010 - Polyphor and Novartis announce PEMfinder® collaboration.

April 12, 2010 - Polyphor and Axxam SpA announce ion channel collaboration.

February 19, 2010 - Polyphor discovers a new class of antibiotics with a novel mode of action. New weapon in the fight against multi-drug resistant bacteria published in “Science” (click here for German version).

October 31, 2008
- Polyphor to enter into an exclusive agreement with Allergan for the development of Protein Epitope Mimetics (PEM) inhibitors for ophthalmology (click here for German version).

July 9, 2008
- Polyphor successfully completes Phase I clinical trials of POL6326 (click here for German version). 

Polyphor Ltd
Hegenheimermattweg 125
CH-4123 Allschwil
Switzerland
Tel. +41 61 567 16 00
Fax +41 61 567 16 01
info@polyphor.com

Last modified:   20.02.2012